Evaluation of the effects of a calcineurin inhibitor in experimental models of Alzheimer’s disease

Sarah Tavares Araújo Santos, Giovanni Freitas Gomes, Nádia Gomes Rocha, Antônio Carlos Pinheiro Oliveira · 2025

Read Evaluation of the effects of a calcineurin inhibitor in experimental models of Alzheimer’s disease by Sarah Tavares Araújo Santos, Giovanni Freitas Gomes, Nádia Gomes Rocha, Antônio Carlos Pinheiro Oliveira (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710743.txt.

Description

Sarah Tavares Araújo Santos and co-authors test a drug in mouse models of Alzheimer's disease in a 2025 study. The drug, FK506, blocks calcineurin, a protein tied to how nerve cells connect and survive. The team asked whether blocking it could protect memory and brain tissue.

They gave the drug to mice harmed by toxins in the hippocampus, to gene-altered mice bred for the disease, and to brain slice cultures. Treated mice kept better memory and social behavior. The drug cut cell death and lowered microglia buildup in the hippocampus. Brain slices also kept more mature nerve cells. The authors see FK506 as a candidate worth more study.

Catalog record

CREATORSarah Tavares Araújo Santos, Giovanni Freitas Gomes, Nádia Gomes Rocha, Antônio Carlos Pinheiro Oliveira
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11710743

Browse the full library · About the Tower of Babel